Clinical Trials
8 trialsNCT00542308 2023-08-03
Zalutumumab in Non-curable Patients With SCCHN
Genmab
Phase 2 Completed
NCT00707655 2023-08-03
Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy
Genmab
Phase 1/2 Terminated
NCT01054625 2023-08-03
Zalutumumab Pharmacokinetics (PK) in Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Genmab
Phase 1/2 Completed
NCT00677924 2023-07-18
GEN206
Genmab
Phase 1/2 Terminated
NCT00093041 2023-06-28
Zalutumumab in Head and Neck Cancer
Genmab
Phase 1/2 Completed
NCT00382031 2013-10-15
Zalutumumab in Patients With Non-curable Head and Neck Cancer
Genmab
Phase 3 Completed
NCT00401401 2011-12-23
Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer
Genmab
Phase 1/2 Terminated
NCT00460551 2011-12-06
Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer
Genmab
Phase 2 Terminated